Levine Keszler has developed a strong practice in biotechnology and life sciences. Levine Keszler’s teams act primarily for developing companies and venture capital funds and work directly with their clients’ business development departments. Levine Keszler assists its clients in drafting their agreements with their main suppliers and subcontractors (CMOs and CROs), their licensing agreements and advises them on their fundraising.
Levine Keszler also regularly represents investment funds in their transactions involving healthcare groups and healthcare companies in their M&A transactions.
Partners
News
Levine Keszler advises Sparring Capital on its majority LBO of Praticima
Levine Keszler advises Sparring Capital on its majority LBO of Praticima
Levine Keszler advises Vebio on its merger with Inovie
Levine Keszler advises Vebio on its merger with Inovie
Levine Keszler is advising AB Science on European Investment Bank funding to support the clinical development programme evaluating masitinib in the treatment of Covid-19.
Levine Keszler is advising AB Science on European Investment Bank funding to support the clinical development programme evaluating masitinib in the treatment of Covid-19.
Levine Keszler advises AB Science on a capital raise
Levine Keszler advises AB Science on a capital raise
Levine Keszler is advising AB Science and Alpha Blue Ocean on an optional equity financing in the form of a PACT™
Levine Keszler is advising AB Science and Alpha Blue Ocean on an optional equity financing in the form of a PACT™
Levine Keszler is advising AB Science on European Investment Bank funding to support the clinical development programme evaluating masitinib in the treatment of Covid-19.
Levine Keszler is advising AB Science on European Investment Bank funding to support the clinical development programme evaluating masitinib in the treatment of Covid-19.
Levine Keszler advises SGH Healthcaring on the acquisitions of Eskiss Packaging and Dosapharm laboratory
Levine Keszler advises SGH Healthcaring on the acquisitions of Eskiss Packaging and Dosapharm laboratory
Levine Keszler advises Maincare Solutions on its acquisition of Anticyclone
Levine Keszler advises Maincare Solutions on its acquisition of Anticyclone
Levine Keszler advises the management of Maincare Solutions in the majority LBO led by Montagu Private Equity
Levine Keszler advises the management of Maincare Solutions in the majority LBO led by Montagu Private Equity
Expertise, Excellence, Innovation, Agility, Flexibility
